At Manningham Medical Centre, you can find all the data about Nerviano Medical Sciences Novartis. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Nerviano Medical Sciences announces new License Agreement …

    https://develop.nervianoms.com/news-media/archivio-storico/nerviano-medical-sciences-announces-new-license-agreement-with-novartis/
    Nerviano Medical Sciences (NMS) is a research based company dedicated to the discovery and development of breakthrough new chemical entities (NCEs) for the …

Homepage - Nerviano Medical Sciences

    https://www.nervianoms.com/
    Nerviano Medical Sciences S.r.l is focused on discovery and clinical development of small molecule NCEs for oncology. The company takes innovative approaches on novel mechanisms of action and drug …

Nerviano Medical Sciences - Part of NMS Group | LinkedIn

    https://www.linkedin.com/company/nerviano-medical-sciences-s.r.l.
    Nerviano Medical Sciences S.r.l. names Salvatore Marengoni Galdy, M.D., Global Clinical Lead NERVIANO, 31 October 2022 – Nerviano Medical Sciences Srl (NMS Srl), a member of NMS Group...

Nerviano Medical Sciences Announces New License Agreement …

    http://nmsgdev.nervianoms.com/news-media-en/press-release/archive-record/nerviano-medical-sciences-announces-new-license-agreement-with-novartis/
    Nerviano Medical Sciences (NMS), the largest pharmaceutical R&D facility in Italy and one of the leading oncology-focused, integrated discovery and development companies in …

History - Nerviano Medical Sciences

    https://www.nervianoms.com/history/
    Nerviano site spun off by Pfzier, acquired by CFIC and renamed as “Nerviano Medical Sciences, srl”, (NMS) 2010-2011. Encorafenib enabling IP licensed to Novartis. Kinase …

Nerviano Medical Sciences announces new License Agreement …

    https://develop.nervianoms.com/nerviano-medical-sciences-announces-new-license-agreement-with-novartis/
    Nerviano – 15 March, 2011 - Nerviano Medical Sciences (NMS), the largest pharmaceutical R&D facility in Italy and one of the leading oncology-focused, integrated discovery and …

Pipeline - Nerviano Medical Sciences

    https://www.nervianoms.com/pipeline/
    NMS-293 is a second generation PARP inhibitor that differentiates from other approved or advanced molecules in its unique selectivity for PARP1 vs PARP2 enzymes and low DNA trapping activity, both features potentially …

Clinical programs - Nerviano Medical Sciences

    https://www.nervianoms.com/clinical-programs/
    Nerviano Medical Sciences is a subsidiary of the NMS Group. We are the innovative core of the Group. ABOUT History Mission, Vision and Values Collaboration and Partnership …

Research Overview - Nerviano Medical Sciences

    https://www.nervianoms.com/research-overview/
    Our approaches include exploration of novel mechanisms and synthetic lethality contexts of exquisite sensitivity, identification and validation of innovative targets by genomic and …

Contacts - Nerviano Medical Sciences

    https://www.nervianoms.com/contacts/
    20014 – Nerviano (Milano) Italy Tel. +39.0331.581111 Fax +39.0331.581753 From MALPENSA airport Follow the A8 motorway (green sign) in the direction of Milan. After …



Need more information about Nerviano Medical Sciences Novartis?

At Manningham Medical Centre, we collected data on more than just Nerviano Medical Sciences Novartis. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.